Spectrum Pharmaceuticals
SPPI
$1.03
Share price
0.00%
Change (1 day)
17.05%
Change (1 year)
Categories
Spectrum Pharmaceuticals (SPPI) - P/B ratio
P/B ratio as of September 2023 : 7.89
According to Spectrum Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 7.89.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Spectrum Pharmaceuticals - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 2.09 | -52.3% |
| 2021-12-31 | 4.38 | 18.13% |
| 2020-12-31 | 3.71 | 71.12% |
| 2019-12-31 | 2.17 | -36.55% |
| 2018-12-31 | 3.41 | -37.12% |
| 2017-12-31 | 5.43 | 259.08% |
| 2016-12-31 | 1.51 | -21.77% |
| 2015-12-31 | 1.93 | 7.62% |
| 2014-12-31 | 1.80 | -10.85% |
| 2013-12-31 | 2.01 | -14.54% |
| 2012-12-31 | 2.36 | -47.26% |
| 2011-12-31 | 4.47 | -5.84% |
| 2010-12-31 | 4.75 | 136.7% |
| 2009-12-31 | 2.01 | 128% |
| 2008-12-31 | 0.8796 | -49.53% |
| 2007-12-31 | 1.74 | -42.7% |
| 2006-12-31 | 3.04 | 86.64% |
| 2005-12-31 | 1.63 | -37.42% |
| 2004-12-31 | 2.60 | -6.71% |
| 2003-12-31 | 2.79 | -61.75% |
| 2002-12-31 | 7.30 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.46 | -30.75% | 🇺🇸 USA |
 Novartis NVS | 4.05 | -48.70% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.83 | -76.85% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.58 | -41.86% | 🇺🇸 USA |
 Biogen BIIB | 2.59 | -67.14% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.85 | -51.19% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.08 | -35.55% | 🇬🇧 UK |
 Seagen
SGEN | 15.3 | 94.19% | 🇺🇸 USA |
 Curis CRIS | 2.04 | -74.17% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.52 | -80.70% | 🇮🇱 Israel |